简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2012-03-27 13:49 Covidien plc to Report Second-Quarter Results on April 27, 2012
2012-03-23 16:10 Coca-Cola Releases Water Stewardship Progress Report
2012-03-23 13:41 Covidien Announces Definitive Agreement to Acquire Newport Medical Instruments, Inc.
2012-03-20 15:56 Covidien Announces Definitive Agreement to Acquire superDimension, Ltd.
2012-03-20 15:37 Gemalto to Issue an Additional 15 Million eHealth Cards in 2012 for AOK Insurees
2012-03-16 16:39 The Life-Changing Power of the Arc Trainer: Biggest Loser Contestant, NFL Pro-Bowl Athlete, Ultra-Distance Runner Highlight Benefits of Revolutionary Fitness Machine
2012-03-16 14:30 Welch Allyn Appoints Stephen F. Meyer President and CEO
2012-03-15 15:48 Effrx Announces: FDA approves BINOSTO®, First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
2012-03-15 15:44 Quintiles Highlights Potential of Asia to Transform Biopharma
2012-03-15 13:50 Covidien Declares Quarterly Cash Dividend
2012-03-14 21:00 Cybex, PumpOne Announce Partnership to Enhance Mobile Personal Training, Provide Expert Advice
2012-03-14 16:56 Covidien Announces Results from 2012 Annual General Meeting
2012-03-12 21:00 New Study: Adaptive Motion Trainers Can Put Significant Stress on Knees, May Not Be Best Option for Those with Knee Pain
2012-03-09 18:00 The Prostate Cancer Foundation Expands Global Reach, Adds First Two PCF Young Investigators in China
2012-03-09 16:41 Covidien Expands Global Research and Development Presence
2012-03-08 17:22 GE Healthcare To Acquire Xcellerex Inc., Broadening Capabilities in Growing Biopharmaceutical Manufacture Segment
2012-03-08 17:08 WIN2012 Symposium on Personalized Cancer Medicine Receives Endorsements from ASCO, ESMO, UICC and INCa
2012-03-07 14:10 Excelitas Technologies to Expand Lighting Capabilities for Medical OEMs with Acquisition of the Business of Carsan Engineering
2012-03-07 10:52 S2 Security Introduces Next Generation of Pronto and NetBox Plus
2012-03-05 11:06 Dainippon Sumitomo Pharma Co., Ltd. to Acquire Boston Biomedical, Inc. for up to $2.63 Billion; Acquisition includes a world-leading pipeline targeting cancer stem cells

Business Wire Weibo

Press Releases

Latest Releases